Pancreatic Adenocarcinoma Clinical Trials

305 clinical trials for Pancreatic Adenocarcinoma across international registries, including 68 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE3
• Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma — RECRUITING
• TCR1188-ABC Cells in KRAS-mutated Cancers — RECRUITING · PHASE1
• A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation — RECRUITING · PHASE1
• Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 ) — RECRUITING · PHASE3
• A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors — RECRUITING · PHASE1
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE3
• Pancreatic Cancer Detection Consortium — RECRUITING
• Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" — RECRUITING · NA
• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer — RECRUITING · PHASE1
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types — RECRUITING · PHASE1
• Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors — RECRUITING · PHASE1
• A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors — RECRUITING · PHASE1
• A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer — RECRUITING · NA
• Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer (Feasibility and Safety) — RECRUITING · NA
• Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer — RECRUITING · NA
• MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer — RECRUITING · NA
• CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers — RECRUITING · PHASE2
• Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma — RECRUITING · PHASE1
• Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel — RECRUITING · PHASE1
• Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement. — RECRUITING · NA
• Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT — RECRUITING · PHASE1
• Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery — RECRUITING · PHASE1
• Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders — RECRUITING
• Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC — RECRUITING · PHASE1
• A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation — RECRUITING · PHASE1
• Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors — RECRUITING · PHASE1
• Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion — RECRUITING · PHASE1
• Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI — RECRUITING · PHASE2
• Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC) — RECRUITING · PHASE2
• Immunotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies — RECRUITING · PHASE1
• 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY) — RECRUITING · PHASE1
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — RECRUITING
• mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer — RECRUITING · PHASE2
• Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency — RECRUITING · PHASE2
• Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic Cancer — RECRUITING · PHASE3
• Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) — RECRUITING · PHASE1
• Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer — RECRUITING · PHASE2
• Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma — RECRUITING · PHASE1
• Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC) — RECRUITING
• Evaluating Novel Therapies in ctDNA Positive GI Cancers — RECRUITING · PHASE3
• Activation of Biobank Registry for Bilio-pancreatic Diseases — RECRUITING

Refine this search